PresentationAnd welcome to our next session. I'm the moderator, Sara Nik, an Equity Research VP at H.C. Wainwright. And it's my pleasure to introduce our next presenter, Brian Culley, CEO of Lineage Cell Therapeutics, a clinical stage biotechnology company developing novel cell therapies for neurological and ophthalmic conditions. Brian, the floor is yours.Brian CulleyCEO, President & Director Thank you so much, and good morning, everybody. It's a pleasure to be here. All right. Next slide. So as we're a pu ...